Condition | [Ref.] | OR or RR |
Immune suppression | ||
HIV-positive and tuberculin skin test-positive | 71–73 | 50–110 |
AIDS | 74, 75 | 110–170 |
Solid organ transplantation related to immunosuppressant therapy | 76–78 | 20–74 |
Receiving anti-TNF-α treatment | 79–81 | 1.5–17 |
Corticosteroids >15 mg prednisolone equivalent per day for >2–4 weeks# | 82, 83 | 4.9 |
Malignancy | 4–8 | |
Haematological malignancy (leukemias, lymphomas) | 84 | 16 |
Carcinoma of the head or neck and lung | 85 | 2.5–6.3 |
Gastrectomy | 86, 87 | 2.5 |
Jejunoileal bypass | 88, 89 | 27–63 |
Silicosis | 90–92 | 30 |
Chronic renal failure/haemodialysis | 93, 94 | 10–25 |
Diabetes mellitus | 95–98 | 2–3.6 |
Smoking | 99–103 | 2–3 |
Excessive alcohol use | 104, 105 | 3 |
Underweight | 106, 107 | 2.0–2.6 |
Age <5 yrs (table 3) | 29 | 2–5 |
Level of evidence generally B or C. TNF: tumour necrosis factor. #: the adjusted RR of corticosteroids for the development of tuberculosis has not been convincingly established. Table adapted and updated from various sources 17, 22, 70.